Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Grey

Showing results (211-220 of 256) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Endocrinology and Metabolism|July 1, 2011
Stable bone density in HAART-treated individuals with HIV: a meta-analysisMark J Bolland, Tom K M Wang, Andrew Grey, et al.
BMJ Open|December 17, 2015
Perceptions of generic medication in the general population, doctors and pharmacists: a systematic reviewSarah Colgan, Kate Faasse, Leslie R Martin, et al.
Bioorganic & Medicinal Chemistry|June 4, 2013
Long-chain triazolyl acids as inhibitors of osteoclastogenesisAndrew J Marshall, Jian-Ming Lin, Andrew Grey, et al.
European Journal of Endocrinology|November 13, 2013
The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trialAndrew Grey, Mark Bolland, Sheryl Fenwick, et al.
Bone|April 3, 2012
Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trialAndrew Grey, Mark J Bolland, Anne Horne, et al.
Psychology & Health|October 30, 2015
3-D bone models to improve treatment initiation among patients with osteoporosis: A randomised controlled pilot trialMelika H Stephens, Andrew Grey, Justin Fernandez, et al.
Endocrinology|October 31, 2013
Skeletal actions of fasting-induced adipose factor (FIAF)Jian-ming Lin, Dorit Naot, Maureen Watson, et al.
BMJ (Clinical Research Ed.)|October 1, 2015
Calcium intake and risk of fracture: systematic reviewMark J Bolland, William Leung, Vicky Tai, et al.
Plos One|October 14, 2016
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβSusannah O'Sullivan, Mei Lin Tay, Jian-Ming Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinibSusannah O'Sullivan, Anne Horne, Diana Wattie, et al.
Pageof 26

Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Endocrinology and Metabolism|July 1, 2011
Stable bone density in HAART-treated individuals with HIV: a meta-analysisMark J Bolland, Tom K M Wang, Andrew Grey, et al.
BMJ Open|December 17, 2015
Perceptions of generic medication in the general population, doctors and pharmacists: a systematic reviewSarah Colgan, Kate Faasse, Leslie R Martin, et al.
Bioorganic & Medicinal Chemistry|June 4, 2013
Long-chain triazolyl acids as inhibitors of osteoclastogenesisAndrew J Marshall, Jian-Ming Lin, Andrew Grey, et al.
European Journal of Endocrinology|November 13, 2013
The skeletal effects of pioglitazone in type 2 diabetes or impaired glucose tolerance: a randomized controlled trialAndrew Grey, Mark Bolland, Sheryl Fenwick, et al.
Bone|April 3, 2012
Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trialAndrew Grey, Mark J Bolland, Anne Horne, et al.
Psychology & Health|October 30, 2015
3-D bone models to improve treatment initiation among patients with osteoporosis: A randomised controlled pilot trialMelika H Stephens, Andrew Grey, Justin Fernandez, et al.
Endocrinology|October 31, 2013
Skeletal actions of fasting-induced adipose factor (FIAF)Jian-ming Lin, Dorit Naot, Maureen Watson, et al.
BMJ (Clinical Research Ed.)|October 1, 2015
Calcium intake and risk of fracture: systematic reviewMark J Bolland, William Leung, Vicky Tai, et al.
Plos One|October 14, 2016
Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβSusannah O'Sullivan, Mei Lin Tay, Jian-Ming Lin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 29, 2009
Decreased bone turnover despite persistent secondary hyperparathyroidism during prolonged treatment with imatinibSusannah O'Sullivan, Anne Horne, Diana Wattie, et al.
Pageof 26